Rethinking FP&A for High Growth Life Sciences Companies

When: Wednesday, September 23rd from 8:00 to 10:00 AM

Royal Sonesta Boston – 40 Edwin H Land Boulevard, Cambridge, MA

Join Our Clients:

Merrimack Logo

Against a backdrop of regulatory pressure, M&A activity, drug commercialization obstacles, rising R&D costs, and shrinking R&D pipelines – FP&A teams at high growth life sciences companies face a variety of challenges when it comes to strategic planning, budgeting and forecasting.

Attend this exclusive, invitation-only breakfast event to hear how Cervello clients Momenta Pharmaceuticals and Merrimack Pharmaceuticals, have re-imagined their FP&A processes and approach to technology in light of these very challenges.

Hear how they are using Cloud EPM technology as a catalyst for achieving financial excellence and to becoming a strategic, value-added partner to the business.

At this event you’ll:

  • Network with peers on the current trends and anticipated future challenges for Finance in life sciences companies
  • Discuss how certain companies are addressing these challenges today and in the short term
  • Hear best practices and lessons learned for leveraging Cloud EPM solutions as a platform for enabling close partnership with the business